HIGH SPEED SOLUTION SWITCHER FOR ELECTROPHYSIOLOGY
HIGH SPEED SOLUTION SWITCHER FOR ELECTROPHYSIOLOGY
批准号:
2713839
负责人:
DAVID C HENDERSON
金额:
$9.99万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-30 至 1999-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The ability to rapidly switch between solutions of known concentration
is a powerful tool for the study of ion channels and transporters. For
outside-out patches where the diffusion path is short, the concentration
can probably be changed in less than ten microseconds using an optimally
designed solution switcher. Today's instruments can switch solutions
in about 100 microseconds. The primary goal of this project is to
design and construct a device that can switch solutions in less than 10
microseconds.
The specific project goals are: 1. Construct a dual-stream laminar-low
perfusion "mixer" by micro-machining silicon using photo-lithographic
technologies. Demonstrate parallel flow between two exit streams with
one micrometer separation. Current pulled theta glass devices have
separations of 10 micrometers. 2. Rapidly move the mixer and exit
streams over an isolated patch using a piezoelectric actuator with
optimized mass, stiffness and steps size for this application.
Demonstrate maximum velocities greater than 0.2 meters/second with
minimum overshoot and ringing. 3. Maximize the rate of change at
minimal flow velocity to preserve material and safeguard patch
integrity. 4. Control the velocity of all streams, and the test solution
concentration of one exit stream, via computer. 5. Explore using
electro-osmosis to reduce thickness of the unstirred layer.
PROPOSED COMMERCIAL APPLICATION:
Burleigh's market experience indicates that at least 250 of the 2500
electrophysiology laboratories worldwide can potentially benefit from
this new capability. Burleigh currently sells the LSS-3100 and LSS-3200
piezoelectric positioning system for Fast Solution Switching
applications at the rate of 30 to 40 systems per year. Each system is
7,000 dollars for positioning capability only. This new technology adds
significantly more value to Burleigh's product by incorporating the
mixer and computer controlled pumps. We believe that this new product
could be sold in quantities of 60 to 80 per year for a price of 10,000
to 12,000 dollars.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
High-speed solution switching using piezo-based micropositioning stages.
使用基于压电的微定位平台进行高速解决方案切换。
DOI:
10.1109/10.930905
发表时间:
2001
期刊:
IEEE transactions on bio-medical engineering
影响因子:
--
作者:
[Stilson,S, McClellan,A, Devasia,S]
通讯作者:
Devasia,S
CLINICAL TRIAL: ARIPIPRAZOLE FOR CLOZAPINE ASSOCIATED MEDICAL MORBIDITY
-
批准号:7731263
-
项目类别:
-
资助金额:$0.45万
-
财政年份:2008
-
负责人:DAVID C HENDERSON
-
依托单位:
ARIPIPRAZOLE FOR CLOZAPINE ASSOCIATED MEDICAL MORBIDITY
-
批准号:7731320
-
项目类别:
-
资助金额:$0.26万
-
财政年份:2008
-
负责人:DAVID C HENDERSON
-
依托单位:
ARIPIPRAZOLE FOR CLOZAPINE ASSOCIATED MEDICAL MORBIDITY
-
批准号:7607075
-
项目类别:
-
资助金额:$1.25万
-
财政年份:2006
-
负责人:DAVID C HENDERSON
-
依托单位:
ROSIGLITAZONE FOR CLOZAPINE INDUCED GLUCOSE METABOLISM IMPAIRMENT
-
批准号:7607033
-
项目类别:
-
资助金额:$0.03万
-
财政年份:2006
-
负责人:DAVID C HENDERSON
-
依托单位:
ARIPIPRAZOLE FOR CLOZAPINE ASSOCIATED MEDICAL MORBIDITY
-
批准号:7607116
-
项目类别:
-
资助金额:$0.58万
-
财政年份:2006
-
负责人:DAVID C HENDERSON
-
依托单位:
ARIPIPRAZOLE FOR CLOZAPINE ASSOCIATED MEDICAL MORBIDITY
-
批准号:7374767
-
项目类别:
-
资助金额:$0.12万
-
财政年份:2005
-
负责人:DAVID C HENDERSON
-
依托单位:
ARIPIPRAZOLE FOR CLOZAPINE ASSOCIATED MEDICAL MORBIDITY
-
批准号:7374793
-
项目类别:
-
资助金额:$1.56万
-
财政年份:2005
-
负责人:DAVID C HENDERSON
-
依托单位:
Aripiprazole for Clozapine Associated Medical Morbidity
-
批准号:6999284
-
项目类别:
-
资助金额:$24.92万
-
财政年份:2005
-
负责人:DAVID C HENDERSON
-
依托单位:
Aripiprazole for Clozapine Associated Medical Morbidity
-
批准号:7151989
-
项目类别:
-
资助金额:$24.19万
-
财政年份:2005
-
负责人:DAVID C HENDERSON
-
依托单位:
Aripiprazole for Clozapine Associated Medical Morbidity
-
批准号:6851846
-
项目类别:
-
资助金额:$25.52万
-
财政年份:2005
-
负责人:DAVID C HENDERSON
-
依托单位:
INSULIN SENSITIVITY, INSULIN SECRETION & GLUCOSE UTIL IN SCHIZOPHRENIC PATIENTS
-
批准号:7205031
-
项目类别:
-
资助金额:$0.48万
-
财政年份:2004
-
负责人:DAVID C HENDERSON
-
依托单位:
ROSIGLITAZONE FOR CLOZAPINE INDUCED GLUCOSE METABOLISM IMPAIRMENT
-
批准号:7205076
-
项目类别:
-
资助金额:$1.86万
-
财政年份:2004
-
负责人:DAVID C HENDERSON
-
依托单位:
ROSIGLITAZONE FOR CLOZAPINE INDUCED GLUCOSE METABOLISM IMPAIRMENT
-
批准号:6982600
-
项目类别:
-
资助金额:$0.33万
-
财政年份:2003
-
负责人:DAVID C HENDERSON
-
依托单位:
INSULIN SENSITIVITY, INSULIN SECRETION & GLUCOSE UTIL. IN SCHIZOPHRENIC PATIENTS
-
批准号:6982543
-
项目类别:
-
资助金额:$1.05万
-
财政年份:2003
-
负责人:DAVID C HENDERSON
-
依托单位:
Insulin Sensitivity/Secretion/ Glucose in Schizophrenia
-
批准号:6586429
-
项目类别:
-
资助金额:$20.08万
-
财政年份:2002
-
负责人:DAVID C HENDERSON
-
依托单位:
Insulin Sensitivity/Secretion/ Glucose in Schizophrenia
-
批准号:6574396
-
项目类别:
-
资助金额:$20.08万
-
财政年份:2001
-
负责人:DAVID C HENDERSON
-
依托单位:
Insulin Sensitivity/Secretion/ Glucose in Schizophrenia
-
批准号:6505199
-
项目类别:
-
资助金额:$20.08万
-
财政年份:2000
-
负责人:DAVID C HENDERSON
-
依托单位:
Blood Exposures Among Workers at the Clinical Center and Four Hospitals in Japan
-
批准号:6431890
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:DAVID C HENDERSON
-
依托单位:
The role of neuronal nitric oxide on current vocalization thresholds
-
批准号:8565320
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:DAVID C HENDERSON
-
依托单位:
A non-injurious assay to study mechanisms of transmission of noxious stimulus
-
批准号:8565312
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:DAVID C HENDERSON
-
依托单位: